EE336 Budget Impact Analysis of Zanubrutinib for Patients With Treatment-Naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the United States
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.582
https://www.valueinhealthjournal.com/article/S1098-3015(22)02786-3/fulltext
Title :
EE336 Budget Impact Analysis of Zanubrutinib for Patients With Treatment-Naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02786-3&doi=10.1016/j.jval.2022.09.582
First page :
Section Title :
Open access? :
No
Section Order :
10116